Unlocking Cardioprotective Potential of Gut Microbiome: Exploring Therapeutic Strategies

被引:0
|
作者
Qu, Jun [1 ]
Meng, Fantao [2 ]
Wang, Zhen [1 ]
Xu, Wenhao [1 ]
机构
[1] Yantai Yuhuangding Hosp, Dept Internal Med Cardiovasc, Yantai, Shandong, Peoples R China
[2] Linyi Cent Hosp, Dept Internal Med Cardiovasc, Linyi, Shandong, Peoples R China
关键词
Microbiome dysbiosis; probiotics; prebiotics; synbiotics; TMAO inhibitors; atherosclerosis; INTERNATIONAL SCIENTIFIC ASSOCIATION; TRIMETHYLAMINE-N-OXIDE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CHLAMYDIA-PNEUMONIAE; CONSENSUS STATEMENT; HEART-FAILURE; SUPPLEMENTATION; CONSUMPTION; PROBIOTICS;
D O I
10.4014/jmb.2405.05019
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The microbial community inhabiting the human gut resembles a bustling metropolis, wherein beneficial bacteria play pivotal roles in regulating our bodily functions. These microorganisms adeptly break down resilient dietary fibers to fuel our energy, synthesize essential vitamins crucial for our well-being, and maintain the delicate balance of our immune system. Recent research indicates a potential correlation between alterations in the composition and activities of these gut microbes and the development of coronary artery disease (CAD). Consequently, scientists are delving into the intriguing realm of manipulating these gut inhabitants to potentially mitigate disease risks. Various promising strategies have emerged in this endeavor. Studies have evidenced that probiotics can mitigate inflammation and enhance the endothelial health of our blood vessels. Notably, strains such as Lactobacilli and Bifidobacteria have garnered substantial attention in both laboratory settings and clinical trials. Conversely, prebiotics exhibit anti-inflammatory properties and hold potential in managing conditions like hypertension and hypercholesterolemia. Synbiotics, which synergistically combine probiotics and prebiotics, show promise in regulating glucose metabolism and abnormal lipid profiles. However, uncertainties persist regarding postbiotics, while antibiotics are deemed unsuitable due to their potential adverse effects. On the other hand, TMAO blockers, such as 3,3-dimethyl-1-butanol, demonstrate encouraging outcomes in laboratory experiments owing to their anti-inflammatory and tissue-protective properties. Moreover, fecal transplantation, despite yielding mixed results, warrants further exploration and refinement. In this comprehensive review, we delve into the intricate interplay between the gut microbiota and CAD, shedding light on the multifaceted approaches researchers are employing to leverage this understanding for therapeutic advancements.
引用
收藏
页码:2413 / 2424
页数:12
相关论文
共 50 条
  • [1] Unlocking the potential: exploring the gut microbiome's ability to absorb the antihypertensive Enalapril
    Malik, Saima
    Mukhtar, Imran
    Muzaffar, Humaira
    Nawaz, Laaraib
    Anwar, Haseeb
    ASIAN JOURNAL OF AGRICULTURE AND BIOLOGY, 2025, 2025 (01):
  • [2] The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies
    Zijing Tang
    Shiyan Yu
    Yu Pan
    Journal of Translational Medicine, 21
  • [3] The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies
    Tang, Zijing
    Yu, Shiyan
    Pan, Yu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [4] Unlocking the Secrets of the Gut Microbiome
    不详
    FOOD TECHNOLOGY, 2019, 73 (12) : 20 - 20
  • [5] Gut microbiome and NAFLD: impact and therapeutic potential
    Li, Liwei
    Cai, Fuqing
    Guo, Chen
    Liu, Zheng
    Qin, Jiamin
    Huang, Jiean
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [6] Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target
    Ramezani, Ali
    Massy, Ziad A.
    Meijers, Bjoern
    Evenepoel, Pieter
    Vanholder, Raymond
    Raj, Dominic S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (03) : 483 - 498
  • [7] The gut microbiome as a potential therapeutic target in IgA nephropathy
    Pereira, Ines Miguel
    Pereira, Marta
    Lopes, Jose Antonio
    Gameiro, Joana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [8] Gut microbiome in systemic sclerosis: a potential therapeutic target
    Polkowska-Pruszynska, Beata
    Gerkowicz, Agnieszka
    Rawicz-Pruszynski, Karol
    Krasowska, Dorota
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2022, 39 (01): : 101 - 109
  • [9] The role and therapeutic potential of gut microbiome in severe burn
    Huang, Zhijie
    Huang, Yisheng
    Chen, Jun
    Tang, Zhengming
    Chen, Yuanxin
    Liu, Hongyu
    Huang, Mingshu
    Qing, Ling
    Li, Li
    Wang, Qin
    Jia, Bo
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [10] Unlocking the Potential of the Genitourinary Microbiome
    Bukavina, Laura
    Abbosh, Philip
    EUROPEAN UROLOGY FOCUS, 2024, 10 (06): : 873 - 874